PTC Therapeutics reports Q3 2026 results, raises revenue guidance, advances pipelineOct 29Quarterly updatePTC Therapeuticssepiapterin
PTC Therapeutics reports Q2 2026 revenue of $361 million, raises full-year guidanceJul 30Quarterly updatePTC Therapeuticssepiapterin